On November 18, 2021 Halozyme Therapeutics, Inc. (NASDAQ: HALO) reported that it will participate at the following investor conferences (Press release, Halozyme, NOV 18, 2021, View Source [SID1234595800]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

33rd Annual Piper Sandler Virtual Healthcare Conference , Elaine Sun, senior vice president and chief financial officer, will represent the company in an on-demand, pre-recorded fireside chat that will be made available on the conference website starting on Monday, November 22, 2021, at 10:00 a.m. ET.
Evercore ISI 4th Annual HealthCONx Conference on Wednesday December 1, 2021, at 3:55 p.m. Eastern Time / 12:55 p.m. Pacific Time. Dr. Helen Torley, president and chief executive officer will represent the company in a virtual fireside chat.
A direct link to the presentations can be accessed through the "Investors" section of www.halozyme.com, and a recording will be made available for 6 months following the events. To access the link, please visit Halozyme’s website approximately 10 minutes prior to the presentation to register and download any necessary audio software.